Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction

Journal of Medicinal Chemistry
Marlon D CowartAndrew O Stewart

Abstract

A new class of agents with potential utility for the treatment of erectile dysfunction has been discovered, guided by the hypothesis that selective D4 agonists are erectogenic but devoid of the side effects typically associated with dopaminergic agents. The lead agent 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (1, ABT-724) was discovered by optimization of a series of benzimidazole arylpiperazines. This highly selective D4 agonist was found to be very potent and efficacious in vivo, eliciting penile erections in rats at a dose of 0.03 micromol/kg, with a positive response rate of 77% erectile incidence. Even at high doses, it was devoid of side effects in animal models of central nervous system behaviors, emesis, or nausea. The structure-activity relationship of the parent benzimidazole series leading to 1 is described, with the detailed in vitro and in vivo profiles described. Distinctive structural features were discovered that are associated with D4 selective agonism in this series of analogues.

References

Jul 1, 1983·Pharmacopsychiatria·H P Vogel, R Schiffter
Jun 6, 1997·Journal of Medicinal Chemistry·S A GlaseL D Wise
Jun 1, 1997·Trends in Pharmacological Sciences·L J BristowG R Seabrook
Jul 1, 1997·Progress in Neuro-psychopharmacology & Biological Psychiatry·V H SethyH Wu
Jul 11, 1998·The Journal of Biological Chemistry·U Gether, B K Kobilka
May 21, 1999·Analytical Biochemistry·P CowardB R Conklin
Mar 25, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J J Clifford, J L Waddington
Jan 31, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Thomas A PugsleyLawrence D Wise
Mar 23, 2002·Neurology·Jean P Hubble
Oct 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·Gin C HsiehJorge D Brioni
Apr 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jorge D BrioniJames P Sullivan

❮ Previous
Next ❯

Citations

Mar 5, 2013·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Peter J GaskillJoan W Berman
Sep 5, 2008·The Journal of Organic Chemistry·Jennifer M Goss, Scott E Schaus
Mar 11, 2010·The Journal of Pharmacology and Experimental Therapeutics·David F CummingsJohn A Schetz
Feb 19, 2010·Cellular and Molecular Life Sciences : CMLS·Pieter RondouKathleen Van Craenenbroeck
Sep 28, 2005·Expert Opinion on Therapeutic Targets·Yasin TemelVeerle Visser-Vandewalle
Mar 6, 2015·Expert Opinion on Emerging Drugs·Taylor C PeakWayne J G Hellstrom
Sep 10, 2014·Expert Opinion on Drug Discovery·Haroldo A Toque, Robert William Caldwell
Jul 3, 2007·Expert Opinion on Emerging Drugs·Stefan UckertUdo Jonas
Aug 20, 2015·Pharmacology, Biochemistry, and Behavior·Fabrizio SannaAntonio Argiolas
Dec 14, 2011·Maturitas·Steve K Williams, Arnold Melman
Sep 13, 2005·Pharmacology, Biochemistry, and Behavior·Robert B MorelandJorge D Brioni
Mar 28, 2006·Bioorganic & Medicinal Chemistry Letters·Stefan LöberPeter Gmeiner
Jan 1, 2008·Bioorganic & Medicinal Chemistry Letters·Rainer TietzeOlaf Prante
May 18, 2005·Bioorganic & Medicinal Chemistry·Xueqing WangAndrew O Stewart
Aug 16, 2016·F1000Research·Chintan K Patel, Nelson Bennett
Sep 13, 2005·Oncogene·Ralph GrassmannKuan-Teh Jeang
May 24, 2012·The Journal of Pharmacology and Experimental Therapeutics·Philippe HuotJonathan M Brotchie
Oct 11, 2014·Archiv der Pharmazie·Ankita RathoreMohammad Shaharyar
Jun 20, 2019·Current Urology Reports·Darshan P PatelJames M Hotaling
Nov 28, 2020·The Journal of Sexual Medicine·Masaru YoshizumiHirokazu Mizoguchi
Jul 29, 2020·Nuclear Medicine and Biology·Michael WillmannBernd Neumaier
Jan 11, 2021·European Journal of Medicinal Chemistry·Gianfabio GiorgioniAlessandro Piergentili
Oct 27, 2006·The Journal of Organic Chemistry·Kenneth M EngstromAndrew O Stewart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.